Background: Cancer is one of the major leading causes of death across the globe. Accurate grading and staging of malignancy are
extremely important. Histopathology is the gold standard for grading of tumors. However, with the advent of immune
histochemistry the tumor proliferative behavior can be more accurately interpreted. So, it is important to assess the tumor grades on
histopathology with their corresponding immunohistochemical profile. Aim: To assess the histopathological grading status of
tumors in comparison to their proliferative behavior and immunophenotype through immunochemistry. Materials and Methods:
Cases diagnosed with Breast, Oral and Glial cancer were surgically operated. Tumors were graded on histopathology subsequently
subjected to immunohistochemical analysis. The histopathological grading was compared to the Breast carcinoma
immunophenotypes, Glial tumor nuclear proliferative potential with Ki67 and in oral cancer Tp53 mutant gene status respectively.
Chi square test analysis was done. Results: A total of 165 cases of cancer were analyzed. A significant correlation was found between
the histopathological grades and immunophenotypes of Breast (2 א -value= 89.97, p-value=0.0001), Oral (2 א -value= 95.27, p value=
0.0001) and Glial cancers (2 א -value= 43.22, p-value = 0.0001). Conclusion: The study showed that the grades in breast carcinoma
matched with corresponding immunophenotypes. Similarly, when comparing glial tumors and oral carcinomas with Ki67 labelling
index and Tp53 positivity status, higher grades corresponded with higher Ki67 and Tp53 positivity.
Keywords: Histopathology, Immunohistochemistry, Immunophenotypes, Breast carcinoma, glial tumors, Oral carcinoma